Advertisement
UK markets close in 6 hours 15 minutes

  • FTSE 100

    8,105.44
    +26.58 (+0.33%)
     

  • FTSE 250

    19,809.63
    +207.65 (+1.06%)
     

  • AIM

    755.90
    +2.78 (+0.37%)
     

  • GBP/EUR

    1.1655
    -0.0001 (-0.01%)
     

  • GBP/USD

    1.2522
    +0.0011 (+0.09%)
     

  • Bitcoin GBP

    51,458.13
    +278.59 (+0.54%)
     

  • CMC Crypto 200

    1,389.38
    -7.15 (-0.51%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    83.63
    +0.06 (+0.07%)
     

  • GOLD FUTURES

    2,361.30
    +18.80 (+0.80%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,045.96
    +128.68 (+0.72%)
     

  • CAC 40

    8,036.71
    +20.06 (+0.25%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Hofseth Biocare ASA: NEW SHARE CAPITAL INCREASE REGISTERED

Hofseth Biocare ASA
·1-min read

Reference is made to the stock exchange announcement on 16 October 2020 regarding the completion of a private placement (the "Private Placement") in Hofseth BioCare ASA.

The share capital increase pertaining to the Private Placement has now been registered with the Norwegian Register of Business Enterprises. The new registered share capital of the Company is NOK 3,549,003.59 divided by 354,900,359 shares, each with a par value of NOK 0.01.

The new shares will be issued in the VPS and delivered to Hofseth AS as soon as practically possible, in order to settle the share lending agreement entered into in connection with the Private Placement.

For further information, please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act